Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Lapatinib (Primary) ; Capecitabine; Oxaliplatin
- Indications Gastric cancer; Liver metastases
- Focus Biomarker; Therapeutic Use
- 15 Jan 2018 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 06 Jun 2017 Results of a biomarker analysis presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.